Anesthesia and Respiratory Devices Market to Surpass USD 84.50 Bn by 2032

Anesthesia and Respiratory Devices Market is Estimated to Witness High Growth Owing to Increasing Surgical Procedures and Growing Number of Chronic Respiratory Diseases

The Global Anesthesia and Respiratory Devices Market is estimated to be valued at USD 56.12 Bn in 2025, exhibiting a CAGR of 6% over the forecast period (2025-2032). Furthermore, the market is witnessing high adoption of portable devices owing to increasing patient preference for home healthcare. The global anesthesia and respiratory devices market is driven by the increasing number of surgical procedures performed worldwide. Being the most common surgical procedures, such as cardiovascular, orthopedic, and cosmetic surgeries contribute significantly to the growth of the market. Moreover, growing incidence of chronic respiratory diseases including asthma and Chronic obstructive pulmonary disease, COPD also propels the demand for respiratory devices.

Increasing Number of Surgical Procedures is Driving the Demand for Anesthesia and Respiratory Devices

One of the major drivers for the global anesthesia and respiratory devices market is the rising number of surgical procedures performed worldwide every year. With improvements in healthcare infrastructure and access in developing nations, more people are now able to undergo surgeries for both elective as well as non-elective procedures. This high volume of surgeries directly translates to increased sales of anesthesia delivery machines, ventilators, masks, and other respiratory devices that are essential during surgical interventions. Hospitals and healthcare facilities are thus investing more in procuring modern anesthesia and respiratory equipment to handle the growing surgical case load.

Growing Geriatric Population is Fueling the Need for Respiratory Care

Another key growth factor for this market is the expanding aging population susceptible to respiratory diseases. Older people generally have weaker immunity and are more prone to chronic respiratory disorders like chronic obstructive pulmonary disease (COPD) and asthma which may require long-term oxygen therapy or respiratory support. With rising life expectancy worldwide, the number of elderly is projected to increase significantly over the coming years. This will augment the demand for continuous positive airway pressure (CPAP) machines, oxygen concentrators, ventilators, and other home respiratory devices. Countries are also formulating policies and reimbursement schemes to promote home healthcare, further aiding the market growth.

Lack of Skilled Anesthesiologists Acts as a Restraint

The global anesthesia and respiratory devices market faces challenges in terms of shortage of trained anesthesiologists and respiratory therapists in many parts of the world. This is a key restraint especially for developing nations struggling with medical staff crunch. These professionals play a crucial role in handling anesthesia equipment, airway management devices, and ventilators. Their absence can compromise the quality of surgical and respiratory care. Moreover, the specialized training required deters many individuals from opting for these careers. This skilled workforce gap has a limiting impact on the effective and full-scale utilization of advanced respiratory systems and monitors available in the market.

Reimbursement Cuts Hamper Device Adoption

Reimbursement cuts by insurance providers also restrain the market expansion to some extent. Healthcare systems are constantly trying to control escalating costs by lowering insurance payments for both equipment and procedures. This makes hospitals reluctant to replace or upgrade their older devices. Moreover, patients also hesitate to choose expensive therapeutic options due to partial or lack of coverage. All this adversely influences the sales volume of advanced anesthesia workstations priced on the higher side. Vendors therefore focus on launching more affordable product lines for cost-sensitive regions and countries with unfavorable reimbursement situations.

Telemedicine Boom Presents Attractive Opportunities

The COVID-19 pandemic has significantly boosted the scope for telemedicine and remote patient monitoring in respiratory care. With physical distancing becoming the norm, there is immense scope for smart wireless devices that can track vital signs and symptoms remotely. This offers opportunities for companies to launch Bluetooth-enabled spirometers, pulse oximeters, peak flow meters, and other peripherals integrating with telemedicine platforms and apps. Emergency response organizations, paramedics, and intensive care ambulances are also potential adopters of portable ventilators and respiratory diagnostic devices with wireless data transmission capabilities. The market stands to benefit from further technology advancements in this domain.

Growing Healthcare Expenditure of Emerging Economies

Expanding healthcare budgets of developing nations like India, China, Brazil, Indonesia, etc. present lucrative opportunities for anesthesia and respiratory device manufacturers. These markets are witnessing increased government investments and infrastructure developments in the medical field. Better access to healthcare facilities and rising disposable incomes are enabling more people in emerging economies to opt for critical as well as elective surgical treatments. This rapidly growing patient base and developing hospital infrastructure will drive the future demand for anesthesia workstations, ventilators, and other respiratory equipment in such regions undergoing economic transformation. Companies may gain by customizing their offerings as per the requirements of these markets.

Link: https://www.coherentmarketinsights.com/market-insight/anesthesia-and-respiratory-devices-market-532

Key Developments:

• In November 2024, Mindray, a leading medical device company, introduced major upgrades to its A7 and A5 anesthesia systems as part of its A Series Anesthesia lineup. These enhancements include advanced technologies aimed at improving anesthesia precision, enhancing patient safety, and optimizing perioperative efficiency.
• In May 2024, Masimo, a pioneer in medical technology, collaborated with Medable Inc. to integrate its MightySat Rx pulse oximeter into Medable’s evidence-generation platform. This partnership supports eight large-scale pharmaceutical trials on breast and lung cancer, involving over 3,000 patients across 25 countries. In April 2024, Royal Philips, a global leader in health technology, announced plans for a new R&D center within its Healthcare Innovation Center (HIC) in Maharashtra, India. Set to be operational within two years, the facility will focus on sleep & respiratory care, precision diagnosis, image guided therapy, and monitoring.
• In June 2022, Medtronic and GE Healthcare, both renowned for healthcare innovation, received U.S. FDA 510(k) clearance and CE Mark approval to integrate Microstream capnography and INVOS regional oximetry into GE’s CARESCAPE precision monitoring platform. This advancement enhances the ability to monitor respiratory compromise and predict perioperative complications.

Key Player:

GE Healthcare, Philips Healthcare, Drägerwerk AG, Masimo Corporation, Mindray Medical International Limited, Nihon Kohden Corporation, Teleflex Incorporated, Smiths Medical, Baxter International Inc., Fresenius Kabi AG, Getinge AB, Hill-Rom Holdings, Inc., Covidien (Medtronic), ResMed Inc., and Intersurgical Ltd.